Amalgamated Financial’s Guardant Health GH Stock Holding History

Amalgamated Financial’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.38M	Buy	+20,872	New	+$1.43M	0.01%	1053

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Amalgamated Financial's GH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Guardant Health (GH) in Q1 2022: 20,872 shares worth $1.38M. The stake represents 0.01% of the portfolio and ranks #1053 among its holdings.

356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Amalgamated Financial held 20,872 shares of Guardant Health worth $1.38M as of Q1 2022.
Guardant Health was a new Amalgamated Financial position in Q1 2022.
Guardant Health made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1053 holding.
356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.